Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 16, 2026

Back to today

From X

@aleabitoreddit 4 clicks

Serenity on X

$TSM released earnings today. I was more curious about commentary given recent the market panic. For analyst Q&A rounds: Q: Citi explicitly challenged TSMC on AI financing, HBM, CoWoS, lasers and the risk of overbuilding capacity A: $TSM assessed CSP capex, DC construction conditions, customer financial conditions, and supply of critical components. Management's conclusion is still that "demand exceeds supply". As well as that AI accelerator revenue growth could exceed its previous 50%+ CAGR projection through 2029. This is a more meaningful statement since it addresses some concerns regarding recent selloff. Q: JPM asked if wafer supply could be tighter in 2027 than in 2026 (demand visibility) A: Wei (Chairman/CEO) stated $TSM even sends staff to verify DC construction progress on site. And after assessing all the factors, TSMC believes gap between supply and demand remains substantial. It could not determine whether the extent of the gap given customers continues to increase demand. Q: On pricing power: A: Wei responded that there is "no ceiling on TSMC's profitability" but that profits will not surge dramatically overnight. (Source: NextApple, Taiwanese press) Regarding earnings, very strong: as usual - TSMC record profits of $23.6B (68% Y/Y growth), and revenue jumping to $46.72B, beating expectations. - Q4 Guidance was $52.3-$54.3B revenue off 65-67% gross margins. TLDR: - No signs of any slowdown or collapse as AI demand far exceeds supply for foreseeable future. $TSM is probably the fundamental proxy/canary to how the overall AI semi trade is doing. - On financing concerns and fear of overcapacity showing up in semiconductor demand: $TSM specifically examined the risks investors are concerned about now and assessment still points to unmet demand. During the Q&A session, Wei said AI demand was "very, extremely strong," with absolutely no signs of slowing. Underlying AI semi supply chain growth is healthier than recent market panic suggest.
@aleabitoreddit 2 clicks

Serenity on X

Clearly a macro related drop after CPI numbers came out today and further US rate hike anticipation. Since $KOSPI, $SPY, and Nikkei ended up plummeting. There's too many potential second/third order effects that's hard to map due if $CRWV goes down or frontier labs struggle (given contractual obligations). Rate hikes understandably amplifies a lot of those fears. But I do think everything getting sold off together presents opportunities. If $LITE has take/pay contracts + sold out until 2029 for lasers and is being financed by hyperscalers for 2031 demand. The demand visibility + financing (with counterparties like $MSFT or $AMZN) are too solid that I wouldn't bunch companies in the optical sector together (that already have cash on hand via ATMs or private placement). With a neocloud that requires billions in future toxic financing in high rate environments. I think markets will eventually distinguish nuances from actual profitability, financing, and long term demand sustainability rather than just treating everything as one "bubble".
@aleabitoreddit 2 clicks

Serenity on X

It's interesting to see Elon interacting with finance X accounts out of the blue. Then amplifying $CRWV financing concerns, Chinese memory flooding, to AI investors being gamblers recently. With $SPCX and $TSLA, I do think Elon is a visionary but from how it looks from the outside... Amplifying concerns about competitors does make their financing more difficult as a self-fulfilling prophecy. And multiple posts about Chinese memory flooding after calling Samsung/SK Hynix pricing extortion does harm these supplier valuations... The economic incentives of doing so probably benefits Tesla/SpaceX more in the long run, even if everything goes down together. There's merit to a lot of things (I've been voicing Coreweave concerns about debt interest + rate hikes for the longest time...). But much like high end memory flooding to nuances of "No crying in a Casino" when the $AVGO CEO comments were regarding OpenAI ARR datapoints... were missed. You can throw rocks at others when a glass house is propped up by passive index flows

Investor Letters

All letters

2026.42: Home At Last

Stratechery’s weekly bundle covers Apple HomeView and SpaceX’s cellular ambitions.

AAPL $5T
Stratechery by Ben Thompson – On the business, strategy, and impact of technology. 3 clicks

Is The Market Turning The Page?

CoreWeave’s debt and equity price action is framed as a wake-up call for investors amid a broader market discussion.

CRWV $34B
WHAT ARE WE DOING? “Contrarians At The Gate” 51 clicks

PesoRama: Research Flash

PesoRama will reach 54 JOi Dollar Plus stores by November after raising C$28.4 million, funding more than 50 additional Mexican store…

TBBB $6.8B
Atrium Research - Equity Research 6 clicks

Modine Deep Dive

Modine, soon Modexus Solutions, has a $4 billion hyperscaler cooling contract but must ramp factory output and restore margins as data…

MOD $9.2B
CV's Substack 16 clicks
TY · long

Tri-continental CORP

Tri-Continental Corp is presented as a long investment-grade fixed-income idea for portfolios with limited liquidity and diversification.

TY $1.8B
Value Investors Club 2 clicks

AppLovin Deep Dive

AppLovin rebuilt its ad model with AXON 2.0, lifting LTM revenue to about $7 billion and margins to 77% as Unity competition threatens…

APP $88B
Speedwell Research 25 clicks

Constellation: Stars Aligning?

Constellation Brands trades near $127 at roughly 11x next-twelve-month EV/EBIT, with recent business results offsetting concerns over…

STZ $22B
TSOH Investment Research 27 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 52 of 238

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.